Literature DB >> 16920412

A simple and sensitive bioanalytical assay for simultaneous determination of omeprazole and its three major metabolites in human blood plasma using RP-HPLC after a simple liquid-liquid extraction procedure.

Naser L Rezk1, Kevin C Brown, Angela D M Kashuba.   

Abstract

A simple, sensitive and specific reverse-phase high-performance liquid chromatography (HPLC) assay for the simultaneous quantitative determination of omeprazole and its three metabolites in human plasma was developed and validated. This method provides excellent chromatographic resolution and peak shape for the four components and the internal standard within a 17 min run time. The simple extraction method results in a clean base line and relatively high extraction efficiency. The method was validated over the range of 2-2000 ng/mL, with 2.0 ng/mL as the lower limit of quantification. Within- and between-day accuracies for five different concentrations ranged from 95 to 102%, and 95 to 114%, respectively. Within- and between-day precision ranged from 1.1 to 6.3% and 0.5 to 6.2%, respectively. Simplicity and high throughput make this method suitable for clinical pharmacokinetic studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920412     DOI: 10.1016/j.jchromb.2006.07.047

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

1.  Relative bioavailability and pharmacokinetic comparison of two different enteric formulations of omeprazole.

Authors:  Jian Liu; Jian-zhong Shentu; Li-hua Wu; Jing Dou; Qi-yang Xu; Hui-li Zhou; Guo-lan Wu; Ming-zhu Huang; Xing-jiang Hu; Jun-chun Chen
Journal:  J Zhejiang Univ Sci B       Date:  2012-05       Impact factor: 3.066

2.  New sensitive kinetic spectrophotometric methods for determination of omeprazole in dosage forms.

Authors:  Ashraf M Mahmoud
Journal:  Int J Anal Chem       Date:  2009-12-02       Impact factor: 1.885

3.  Developmental pharmacogenetics of CYP2C19 in neonates and young infants: omeprazole as a probe drug.

Authors:  Wei Zhao; Stéphanie Leroux; Valérie Biran; Evelyne Jacqz-Aigrain
Journal:  Br J Clin Pharmacol       Date:  2018-03-09       Impact factor: 4.335

4.  A Single Gradient Stability-Indicating Reversed-Phase LC Method for the Estimation of Impurities in Omeprazole and Domperidone Capsules.

Authors:  Raja Kumar Seshadri; Thummala Veera Raghavaraju; Ivon Elisha Chakravarthy
Journal:  Sci Pharm       Date:  2012-11-19

5.  Hydroxylation index of omeprazole in relation to CYP2C19 polymorphism and sex in a healthy Iranian population.

Authors:  Maryam Payan; Mohammad Reza Rouini; Nader Tajik; Mohammad Hossein Ghahremani; Reza Tahvilian
Journal:  Daru       Date:  2014-12-11       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.